A proteomic view of mycobacteria

Proteomics

Volumn 11, Issue 15, 2011, Pages 3118-3127

  de Souza, Gustavo A ^a,b   Wiker, Harald G ^a,c  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Microbiology; Mycobacterium tuberculosis; Quantitative analysis; Secreted protein

Indexed keywords

BACTERIAL PROTEIN; BCG VACCINE; MEMBRANE PROTEIN;

BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL COMPOSITION; CELL STRUCTURE; DISEASE MODEL; GENETIC VARIABILITY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOGENICITY; IMMUNOLOGY; INFECTION PREVENTION; MICROBIAL DIVERSITY; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEOMICS; REVIEW; STRUCTURAL GENOMICS; TUBERCULOSIS;

ANIMALS; BACTERIAL PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PROTEOME; PROTEOMICS; TUBERCULOSIS;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 79960461488     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100043     Document Type: Review

References (86)

1. Lillebaek, T., Dirksen, A., Baess, I., Strunge, B. et al., Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J. Infect. Dis. 2002, 185, 401-404.
2. Lin, M. Y., Ottenhoff, T. H., Host-pathogen interactions in latent Mycobacterium tuberculosis infection: identification of new targets for tuberculosis intervention. Endocr. Metab. Immune Disord. Drug Targets 2008, 8, 15-29.
3. Hernandez-Pando, R., Jeyanathan, M., Mengistu, G., Aguilar, D. et al., Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet 2000, 356, 2133-2138.
4. Griffith, A. S., Types of tubercle bacilli in human tuberculosis. J. Pathol. Bact. 1929, 32, 813-814.
5. Opie, E. L., Aronson, J. D., Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculous lesions. Arch. Pathol. Lab. Med. 1927, 4, 1-21.
6. Wiker, H. G., Mustafa, T., Bjune, G. A., Harboe, M., Evidence for waning of latency in a cohort study of tuberculosis. BMC Infect. Dis. 2010, 10, 37.
7. Hunter, R. L., Jagannath, C., Actor, J. K., Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs. Tuberculosis 2007, 87, 267-278.
8. Armstrong, J. A., Hart, P. D., Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J. Exp. Med. 1971, 134, 713-740.
9. Winau, F., Weber, S., Sad, S., de Diego, J. et al., Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity 2006, 24, 105-117.
10. Mustafa, T., Phyu, S., Nilsen, R., Bjune, G., Jonsson, R., Increased expression of Fas ligand on Mycobacterium tuberculosis infected macrophages: a potential novel mechanism of immune evasion by Mycobacterium tuberculosis? Inflammation 1999, 23, 507-521.
11. Rook, G. A., Al Attiyah, R., Cytokines and the Koch phenomenon. Tubercle 1991, 72, 13-20.
12. Målen, H., Berven, F. S., Fladmark, K. E., Wiker, H. G., Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics 2007, 7, 1702-1718.
13. Ribeiro-Guimaraes, M. L., Pessolani, M. C., Comparative genomics of mycobacterial proteases. Microb. Pathog. 2007, 43, 173-178.
14. Bloch, H., Studies on the virulence of tubercle bacilli; isolation and biological properties of a constituent of virulent organisms. J. Exp. Med. 1950, 91, 197-218.
15. Hunter, R. L., Olsen, M., Jagannath, C., Actor, J. K., Trehalose 6, 6'-dimycolate and lipid in the pathogenesis of caseating granulomas of tuberculosis in mice. Am. J. Pathol. 2006, 168, 1249-1261.
16. Veyrier, F., Pletzer, D., Turenne, C., Behr, M. A., Phylogenetic detection of horizontal gene transfer during the step-wise genesis of Mycobacterium tuberculosis. BMC Evol. Biol. 2009, 9, 196.
17. Cole, S. T., Eiglmeier, K., Parkhill, J., James, K. D. et al., Massive gene decay in the leprosy bacillus. Nature 2001, 409, 1007-1011.
18. Brosch, R., Gordon, S. V., Marmiesse, M., Brodin, P. et al., A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. USA 2002, 99, 3684-3689.
19. Charlet, D., Mostowy, S., Alexander, D., Sit, L. et al., Reduced expression of antigenic proteins MPB70 and MPB83 in Mycobacterium bovis BCG strains due to a start codon mutation in sigK. Mol. Microbiol. 2005, 56, 1302-1313.
20. Behr, M. A., Wilson, M. A., Gill, W. P., Salamon, H. et al., Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999, 284, 1520-1523.
21. Gagneux, S., DeRiemer, K., Van, T., Kato-Maeda, M. et al., Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 2006, 103, 2869-2873.
22. McEvoy, C. R., Falmer, A. A., Gey van Pittius, N. C., Victor, T. C. et al., The role of IS6110 in the evolution of Mycobacterium tuberculosis. Tuberculosis (Edinb.) 2007, 87, 393-404.
23. Parwati, I., van Crevel, R., van Soolingen, D., Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect. Dis. 2010, 10, 103-111.
24. Homolka, S., Niemann, S., Russell, D. G., Rohde, K. H., Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival. PLoS. Pathog. 2010, 6, e1000988.
25. de Souza, G. A., Fortuin, S., Aguilar, D., Pando, R. H. et al., Using a label-free proteomic method to identify differentially abundant proteins in closely related hypo- and hyper-virulent clinical Mycobacterium tuberculosis Beijing isolates. Mol. Cell. Proteomics 2010, 9, 2414-2423.
26. Tekaia, F., Gordon, S. V., Garnier, T., Brosch, R. et al., Analysis of the proteome of Mycobacterium tuberculosis in silico. Tuber. Lung Dis. 1999, 79, 329-342.
27. Gu, S., Chen, J., Dobos, K. M., Bradbury, E. M. et al., Comprehensive Proteomic Profiling of the Membrane Constituents of a Mycobacterium tuberculosis Strain. Mol. Cell. Proteomics 2003, 2, 1284-1296.
28. Zheng, J., Wei, C., Leng, W., Dong, J. et al., Membrane subproteomic analysis of Mycobacterium bovis bacillus Calmette-Guerin. Proteomics 2007, 7, 3919-3931.
29. Målen, H., Berven, F. S., Søfteland, T., Arntzen, M. Ø. et al., Membrane and membrane-associated proteins in Triton X-114 extracts of Mycobacterium bovis BCG identified using a combination of gel-based and gel-free fractionation strategies. Proteomics 2008, 8, 1859-1870.
30. Zheng, J., Wei, C., Zhao, L., Liu, L. et al., Combining blue native polyacrylamide gel electrophoresis with liquid chromatography tandem mass spectrometry as an effective strategy for analyzing potential membrane protein complexes of Mycobacterium bovis bacillus Calmette-Guerin. BMC Genomics 2011, 12, 40.
31. de Souza, G. A., Arntzen, M. Ø., Wiker, H. G., MSMSpdbb: providing protein databases of closely related organisms to improve proteomic characterization of prokaryotic microbes. Bioinformatics 2010, 26, 698-699.
32. de Souza, G. A., Arntzen, M. Ø., Fortuin, S., Schurch, A. C. et al., Proteogenomic analysis of polymorphisms and gene annotation divergences in prokaryotes using a clustered mass spectrometry-friendly database. Mol. Cell. Proteomics 2011, 10, 1-10.
33. de Souza, G. A., Målen, H., Søfteland, T., Sćlensminde, G. et al., High accuracy mass spectrometry analysis as a tool to verify and improve gene annotation using Mycobacterium tuberculosis as an example. BMC Genomics 2008, 9, 316.
34. de Souza, G. A., Søfteland, T., Koehler, C. J., Thiede, B., Wiker, H. G., Validating divergent ORF annotation of the Mycobacterium leprae genome through a full translation data set and peptide identification by tandem mass spectrometry. Proteomics 2009, 9, 3233-3243.
35. de Souza, G. A., Wiker, H. G., The impact of proteomic advances on bacterial gene annotation. Curr. Proteomics 2009, 6, 84-92.
36. Leversen, N. A., de Souza, G. A., Målen, H., Prasad, S. et al., Evaluation of signal peptide prediction algorithms for identification of mycobacterial signal peptides using sequence data from proteomic methods. Microbiology 2009, 155, 2375-2383.
37. Ishihama, Y., Oda, Y., Tabata, T., Sato, T. et al., Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell. Proteomics 2005, 4, 1265-1272.
38. Cox, J., Mann, M., MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 2008, 26, 1367-1372.
39. Deutscher, J., Saier, M. H., Jr, Ser/Thr/Tyr protein phosphorylation in bacteria - for long time neglected, now well established. J. Mol. Microbiol. Biotechnol. 2005, 9, 125-131.
40. VanderVen, B. C., Harder, J. D., Crick, D. C., Belisle, J. T., Export-mediated assembly of mycobacterial glycoproteins parallels eukaryotic pathways. Science 2005, 309, 941-943.
41. Av-Gay, Y., Everett, M., The eukaryotic-like Ser/Thr protein kinases of Mycobacterium tuberculosis. Trends Microbiol. 2000, 8, 238-244.
42. Pearce, M. J., Mintseris, J., Ferreyra, J., Gygi, S. P., Darwin, K. H., Ubiquitin-like protein involved in the proteasome pathway of Mycobacterium tuberculosis. Science 2008, 322, 1104-1107.
43. Prisic, S., Dankwa, S., Schwartz, D., Chou, M. F. et al., Extensive phosphorylation with overlapping specificity by Mycobacterium tuberculosis serine/threonine protein kinases. Proc. Natl. Acad. Sci. USA 2010, 107, 7521-7526.
44. Poulsen, C., Akhter, Y., Jeon, A. H., Schmitt-Ulms, G. et al., Proteome-wide identification of mycobacterial pupylation targets. Mol. Syst. Biol. 2010, 6, 386.
45. Braibant, M., Lefevre, P., De Wit, L., Peirs, P. et al., A Mycobacterium tuberculosis gene cluster encoding proteins of a phosphate transporter homologous to the Escherichia coli Pst system. Gene 1996, 176, 171-176.
46. Harboe, M., Wiker, H. G., Ulvund, G., Lund-Pedersen, B. et al., MPB70 and MPB83 as indicators of protein localization in mycobacterial cells. Infect. Immun. 1998, 66, 289-296.
47. Young, D. B., Garbe, T. R., Lipoprotein antigens of Mycobacterium tuberculosis. Res. Microbiol. 1991, 142, 55-65.
48. Michell, S. L., Whelan, A. O., Wheeler, P. R., Panico, M. et al., The MPB83 antigen from Mycobacterium bovis contains O-linked mannose and (1-->3)-mannobiose moieties. J. Biol. Chem. 2003, 278, 16423-16432.
49. Sartain, M. J., Belisle, J. T., N-Terminal clustering of the O-glycosylation sites in the Mycobacterium tuberculosis lipoprotein SodC. Glycobiology 2009, 19, 38-51.
50. Dobos, K. M., Khoo, K. H., Swiderek, K. M., Brennan, P. J., Belisle, J. T., Definition of the full extent of glycosylation of the 45-kilodalton glycoprotein of Mycobacterium tuberculosis. J. Bacteriol. 1996, 178, 2498-2506.
51. Nagai, S., Wiker, H. G., Harboe, M., Kinomoto, M., Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect. Immun. 1991, 59, 372-382.
52. Guerrero, G. G., Debrie, A. S., Locht, C., Boosting with mycobacterial heparin-binding haemagglutinin enhances protection of Mycobacterium bovis BCG-vaccinated newborn mice against M. tuberculosis. Vaccine 2010, 28, 4340-4347.
53. Vidal Pessolani, M. C., Marques, M. A., Reddy, V. M., Locht, C., Menozzi, F. D., Systemic dissemination in tuberculosis and leprosy: do mycobacterial adhesins play a role? Microbes. Infect. 2003, 5, 677-684.
54. Pethe, K., Bifani, P., Drobecq, H., Sergheraert, C. et al., Mycobacterial heparin-binding hemagglutinin and laminin-binding protein share antigenic methyllysines that confer resistance to proteolysis. Proc. Natl. Acad. Sci. USA 2002, 99, 10759-10764.
55. Temmerman, S., Pethe, K., Parra, M., Alonso, S. et al., Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin. Nat. Med. 2004, 10, 935-941.
56. Wiker, H. G., Harboe, M., Nagai, S., Patarroyo, M. E. et al., MPB59, A widely cross-reacting protein of Mycobacterium bovis BCG. Int. Arch. Allergy Appl. Immunol. 1986, 81, 307-314.
57. Wiker, H. G., Harboe, M., The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol. Rev. 1992, 56, 648-661.
58. Wiker, H. G., Harboe, M., Lea, T. E., Purification and characterization of two protein antigens from the heterogeneous BCG85 complex in Mycobacterium bovis BCG. Int. Arch. Allergy Appl. Immunol. 1986, 81, 298-306.
59. Harboe, M., Nagai, S., Patarroyo, M. E., Torres, M. L. et al., Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG. Infect. Immun. 1986, 52, 293-302.
60. Nagai, S., Miura, K., Tokunaga, T., Harboe, M., MPB70, a unique antigenic protein isolated from the culture filtrate of BCG substrain Tokyo. Dev. Biol. Stand. 1986, 58, 511-516.
61. Andersen, A. B., Hansen, E. B., Structure and mapping of antigenic domains of protein antigen b, a 38, 000-molecular-weight protein of Mycobacterium tuberculosis. Infect. Immun. 1989, 57, 2481-2488.
62. Daniel, T. M., Ellner, J. J., Todd, L. S., McCoy, D. W. et al., Immunobiology and species distribution of Mycobacterium tuberculosis antigen 5. Infect. Immun. 1979, 24, 77-82.
63. Belisle, J. T., Vissa, V. D., Sievert, T., Takayama, K. et al., Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 1997, 276, 1420-1422.
64. Rosenkrands, I., King, A., Weldingh, K., Moniatte, M. et al., Towards the proteome of Mycobacterium tuberculosis. Electrophoresis 2000, 21, 3740-3756.
65. Mattow, J., Schaible, U. E., Schmidt, F., Hagens, K. et al., Comparative proteome analysis of culture supernatant proteins from virulent Mycobacterium tuberculosis H37Rv and attenuated M. bovis BCG Copenhagen. Electrophoresis 2003, 24, 3405-3420.
66. Wiker, H. G., Harboe, M., Nagai, S., A localization index for distinction between extracellular and intracellular antigens of Mycobacterium tuberculosis. J. Gen. Microbiol. 1991, 137, 875-884.
67. Abou-Zeid, C., Smith, I., Grange, J. M., Ratliff, T. L. et al., The secreted antigens of Mycobacterium tuberculosis and their relationship to those recognized by the available antibodies. J. Gen. Microbiol. 1988, 134, 531-538.
68. Andersen, P., Askgaard, D., Ljungqvist, L., Bennedsen, J., Heron, I., Proteins released from Mycobacterium tuberculosis during growth. Infect. Immun. 1991, 59, 1905-1910.
69. Andersen, P., Askgaard, D., Ljungqvist, L., Bentzon, M. W., Heron, I., T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect. Immun. 1991, 59, 1558-1563.
70. Andersen, P., Andersen, A. B., Sørensen, A. L., Nagai, S., Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J. Immunol. 1995, 154, 3359-3372.
71. Berthet, F. X., Rasmussen, P. B., Rosenkrands, I., Andersen, P., Gicquel, B., A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology 1998, 144, 3195-3203.
72. Rosenkrands, I., Weldingh, K., Jacobsen, S., Hansen, C. V. et al., Mapping and identification of Mycobacterium tuberculosis proteins by two-dimensional gel electrophoresis, microsequencing and immunodetection. Electrophoresis 2000, 21, 935-948.
73. Weldingh, K., Rosenkrands, I., Jacobsen, S., Rasmussen, P. B. et al., Two-dimensional electrophoresis for analysis of Mycobacterium tuberculosis culture filtrate and purification and characterization of six novel proteins. Infect. Immun. 1998, 66, 3492-3500.
74. Fukui, Y., Hirai, T., Uchida, T., Yoneda, M., Extracellular proteins of tubercle bacilli. IV. Alpha and beta antigens as major extracellular protein products and as cellular components of a strain (H37Rv) of Mycobacterium tuberculosis. Biken. J. 1965, 8, 189-199.
75. Wiker, H. G., Tomazella, G. G., de Souza, G. A., A quantitative view on Mycobacterium leprae antigens by proteomics. J. Proteomics 2011. E-pub ahead of print.
76. Andersen, P., Doherty, T. M., TB subunit vaccines-putting the pieces together. Microbes Infect. 2005, 7, 911-921.
77. Målen, H., Søfteland, T., Wiker, H. G., Antigen analysis of Mycobacterium tuberculosis H37Rv culture filtrate proteins. Scand. J. Immunol. 2008, 67, 245-252.
78. Kunnath-Velayudhan, S., Salamon, H., Wang, H. Y., Davidow, A. L. et al., Dynamic antibody responses to the Mycobacterium tuberculosis proteome. Proc. Natl. Acad. Sci. USA 2010, 107, 14703-14708.
79. Mattow, J., Siejak, F., Hagens, K., Becher, D. et al., Proteins unique to intraphagosomally grown Mycobacterium tuberculosis. Proteomics 2006, 6, 2485-2494.
80. Shui, W., Gilmore, S. A., Sheu, L., Liu, J. et al., Quantitative proteomic profiling of host-pathogen interactions: the macrophage response to Mycobacterium tuberculosis lipids. J. Proteome Res. 2009, 8, 282-289.
81. Rao, P. K., Singh, C. R., Jagannath, C., Li, Q., A systems biology approach to study the phagosomal proteome modulated by mycobacterial infections. Int. J. Clin. Exp. Med. 2009, 2, 233-247.
82. Kruh, N. A., Troudt, J., Izzo, A., Prenni, J., Dobos, K. M., Portrait of a pathogen: the Mycobacterium tuberculosis proteome in vivo. PLoS. One 2010, 5, e13938.
83. Dormans, J., Burger, M., Aguilar, D., Hernandez-Pando, R. et al., Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model. Clin. Exp. Immunol. 2004, 137, 460-468.
84. He, X. Y., Zhuang, Y. H., Zhang, X. G., Li, G. L., Comparative proteome analysis of culture supernatant proteins of Mycobacterium tuberculosis H37Rv and H37Ra. Microbes Infect. 2003, 5, 851-856.
85. Målen, H., de Souza, G. A., Pathak, S., Søfteland, T., Wiker, H. G., Comparison of membrane proteins of Mycobacterium tuberculosis H37Rv and H37Ra strains. BMC Microbiol. 2011, 11, 18.
86. Shimono, N., Morici, L., Casali, N., Cantrell, S. et al., Hypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce1 operon. Proc. Natl. Acad. Sci. USA 2003, 100, 15918-15923.